Farther Finance Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Buy
3,710
+265
+8% +$82.2K 0.01% 1050
2026
Q2
$965K Buy
3,445
+28
+0.8% +$7.36K 0.01% 1127
2026
Q1
$932K Buy
3,417
+844
+33% +$229K 0.01% 1011
2025
Q4
$646K Buy
2,573
+79
+3% +$21K 0.01% 1150
2025
Q3
$716K Buy
2,494
+137
+6% +$36.7K 0.01% 891
2025
Q2
$619K Buy
2,357
+508
+27% +$124K 0.01% 811
2025
Q1
$430K Sell
1,849
-1,228
-40% -$298K 0.01% 849
2024
Q4
$706K Buy
3,077
+1,692
+122% +$388K 0.03% 480
2024
Q3
$310K Buy
1,385
+208
+18% +$45.7K 0.01% 814
2024
Q2
$239K Buy
1,177
+527
+81% +$107K 0.01% 769
2024
Q1
$141K Sell
650
-69
-10% -$15.2K 0.01% 824
2023
Q4
$163K Buy
719
+39
+6% +$8.19K 0.01% 622
2023
Q3
$137K Buy
680
+291
+75% +$61.4K 0.02% 471
2023
Q2
$80.6K Buy
389
+93
+31% +$18K 0.02% 525
2023
Q1
$58.3K Buy
296
+4
+1% +$823 0.02% 565
2022
Q4
$59.1K Buy
+292
New +$57.1K 0.02% 453

Other funds holding LH

Farther Finance Advisors's LH Position: Q3 2026 in Review

Farther Finance Advisors increased its Labcorp (LH) stake by 7.7% in Q3 2026, buying an estimated $82.2K and bringing the position to 3,710 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #1050.

Farther Finance Advisors first reported a position in LH in Q4 2022 and has held it in 16 quarters since. 32 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Farther Finance Advisors held 3,710 shares of Labcorp worth $1.14M as of Q3 2026.
  • Farther Finance Advisors bought 265 Labcorp shares in Q3 2026, an estimated $82.2K.
  • Labcorp made up 0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1050 holding.
  • Farther Finance Advisors first reported a position in Labcorp in Q4 2022 and has held it in 16 quarters since.
  • 32 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.